{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:42:27Z","timestamp":1790217747840,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Antifungal resistance due to upregulation of efflux pumps is prevalent in clinical\n                    <jats:italic>Candida<\/jats:italic>\n                    isolates. Potential efflux pump substrates (PEPSs), which are active against strains deficient in efflux pumps but inactive against wild-type strains, are usually missed in routine antifungal screening. Here we present a method for identification of PEPSs, and show that conjugation with mitochondria-targeting triphenylphosphonium cation (TPP\n                    <jats:sup>+<\/jats:sup>\n                    ) can enhance or restore the compounds\u2019 antifungal activity. The screening method involves co-culturing a wild-type\n                    <jats:italic>C. albicans<\/jats:italic>\n                    strain and a Cdr efflux pump-deficient strain, labelled with different fluorescent proteins. We identify several PEPSs from a library of natural terpenes, and restore their antifungal activity against wild-type and azole-resistant\n                    <jats:italic>C. albicans<\/jats:italic>\n                    by conjugation with TPP\n                    <jats:sup>+<\/jats:sup>\n                    . The most active conjugate (IS-2-Pi-TPP) kills\n                    <jats:italic>C. albicans<\/jats:italic>\n                    cells, prevents biofilm formation and eliminates preformed biofilms, without inducing significant resistance. The antifungal activity is accompanied by mitochondrial dysfunction and increased levels of intracellular reactive oxygen species. In addition, IS-2-Pi-TPP is effective against\n                    <jats:italic>C. albicans<\/jats:italic>\n                    in a mouse model of skin infection.\n                  <\/jats:p>","DOI":"10.1038\/s41467-018-07633-9","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T07:32:08Z","timestamp":1543217528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Efflux pump-mediated resistance to antifungal compounds can be prevented by conjugation with triphenylphosphonium cation"],"prefix":"10.1038","volume":"9","author":[{"given":"Wenqiang","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhuo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiguo","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"7633_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","volume":"74","author":"M Pfaller","year":"2012","unstructured":"Pfaller, M. et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance\u00ae) registry, 2004-2008. Diagn. Microbiol. Infect. Dis. 74, 323\u2013331 (2012).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"7633_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cmi.2015.09.018","volume":"22","author":"R Rajendran","year":"2016","unstructured":"Rajendran, R. et al. Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013. Clin. Microbiol. Infect. 22, 74\u201376 (2016).","journal-title":"Clin. Microbiol. Infect."},{"key":"7633_CR3","doi-asserted-by":"publisher","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"GD Brown","year":"2012","unstructured":"Brown, G. D. et al. Hidden killers: human fungal infections. Sci. Transl. Med. 4, 165rv13 (2012).","journal-title":"Sci. Transl. Med."},{"key":"7633_CR4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","volume":"125","author":"MA Pfaller","year":"2012","unstructured":"Pfaller, M. A. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am. J. Med. 125, S3\u201313 (2012).","journal-title":"Am. J. Med."},{"key":"7633_CR5","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/cid\/cis697","volume":"55","author":"AA Cleveland","year":"2012","unstructured":"Cleveland, A. A. et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011. Clin. Infect. Dis. 55, 1352\u20131361 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"7633_CR6","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1126\/science.aaa6097","volume":"347","author":"DW Denning","year":"2015","unstructured":"Denning, D. W. & Bromley, M. J. Infectious disease. How to bolster the antifungal pipeline. Science 347, 1414\u20131416 (2015).","journal-title":"Science"},{"key":"7633_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrd3074","volume":"9","author":"L Ostroskyzeichner","year":"2010","unstructured":"Ostroskyzeichner, L., Casadevall., A., Galgiani, J. N., Odds, F. C. & Rex, J. H. An insight into the antifungal pipeline: selected new molecules and beyond. Nat. Rev. Drug. Discov. 9, 719\u2013727 (2010).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"7633_CR8","doi-asserted-by":"publisher","first-page":"a019752","DOI":"10.1101\/cshperspect.a019752","volume":"5","author":"LE Cowen","year":"2014","unstructured":"Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D. & Perlin, D. S. Mechanisms of antifungal drug resistance. Cold Spring Harb. Perspect. Med. 5, a019752 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"7633_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-3-319-50409-4_15","volume-title":"Candida albicans: Cellular and Molecular Biology","author":"Dominique Sanglard","year":"2017","unstructured":"Sanglard, D. Mechanisms of drug resistance in Candida albicans. In: Prasad Rajendra (editor) Candida albicans: Cellular and Molecular Biology, 287\u2013311 (Springer, Cham, Switzerland, 2017)."},{"key":"7633_CR10","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","volume":"41","author":"TC White","year":"1997","unstructured":"White, T. C. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41, 1482\u20131487 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7633_CR11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1128\/EC.00151-07","volume":"6","author":"A Coste","year":"2007","unstructured":"Coste, A. et al. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot. Cell 6, 1889\u20131904 (2007).","journal-title":"Eukaryot. Cell"},{"key":"7633_CR12","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1534\/genetics.105.054767","volume":"172","author":"A Coste","year":"2006","unstructured":"Coste, A. et al. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172, 2139\u20132156 (2006).","journal-title":"Genetics"},{"key":"7633_CR13","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1371\/journal.ppat.0030164","volume":"3","author":"J Morschh\u00e4user","year":"2007","unstructured":"Morschh\u00e4user, J. et al. The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog. 3, e164 (2007).","journal-title":"PLoS Pathog."},{"key":"7633_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 79, 629\u2013661 (2016).","journal-title":"J. Nat. Prod."},{"key":"7633_CR15","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.2217\/fmb.15.67","volume":"10","author":"LL Silver","year":"2015","unstructured":"Silver, L. L. Natural products as a source of drug leads to overcome drug resistance. Future Microbiol. 10, 1711\u20131718 (2015).","journal-title":"Future Microbiol."},{"key":"7633_CR16","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1016\/j.bmc.2017.09.001","volume":"25","author":"S Li","year":"2017","unstructured":"Li, S. et al. Eudesmane sesquiterpenes from Chinese liverwort are substrates of Cdrs and display antifungal activity by targeting Erg6 and Erg11 of Candida albicans. Bioorg. Med. Chem. 25, 5764\u20135771 (2017).","journal-title":"Bioorg. Med. Chem."},{"key":"7633_CR17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1055\/s-0042-108207","volume":"82","author":"A Azzollini","year":"2016","unstructured":"Azzollini, A. et al. Preparative scale MS-guided isolation of bioactive compounds using high-resolution flash chromatography: antifungals from Chiloscyphus polyanthos as a case study. Planta Med. 82, 1051\u20131057 (2016).","journal-title":"Planta Med."},{"key":"7633_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10333","volume":"7","author":"R Chait","year":"2016","unstructured":"Chait, R., Palmer, A. C., Yelin, I. & Kishony, R. Pervasive selection for and against antibiotic resistance in inhomogeneous multistress environments. Nat. Commun. 7, 10333 (2016).","journal-title":"Nat. Commun."},{"key":"7633_CR19","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/nchembio.2176","volume":"12","author":"LK Stone","year":"2016","unstructured":"Stone, L. K. et al. Compounds that select against the tetracycline-resistance efflux pump. Nat. Chem. Biol. 12, 902\u2013904 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"7633_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.fct.2017.09.026","volume":"109","author":"W Chang","year":"2017","unstructured":"Chang, W. et al. Solasodine-3-O-\u03b2-d-glucopyranoside is hydrolyzed by a membrane glucosidase into active molecule solasodine against Candida albicans. Food Chem. Toxicol. 109, 356\u2013362 (2017).","journal-title":"Food Chem. Toxicol."},{"key":"7633_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1126\/science.8153625","volume":"264","author":"H Nikaido","year":"1994","unstructured":"Nikaido, H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264, 382\u2013388 (1994).","journal-title":"Science"},{"key":"7633_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.addr.2015.02.008","volume":"87","author":"P Boisgu\u00e9rin","year":"2015","unstructured":"Boisgu\u00e9rin, P. et al. Delivery of therapeutic oligonucleotides with cell penetrating peptides. Adv. Drug Deliv. Rev. 87, 52\u201367 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"7633_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2174\/1568026615666150302105622","volume":"15","author":"JT Madak","year":"2015","unstructured":"Madak, J. T. & Neamati, N. Membrane permeable lipophilic cations as mitochondrial directing groups. Curr. Top. Med. Chem. 15, 745\u2013766 (2015).","journal-title":"Curr. Top. Med. Chem."},{"key":"7633_CR24","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1021\/mp500038g","volume":"11","author":"M Han","year":"2014","unstructured":"Han, M. et al. Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435\/DOX cells. Mol. Pharm. 11, 2640\u20132649 (2014).","journal-title":"Mol. Pharm."},{"key":"7633_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1021\/acschembio.5b00708","volume":"11","author":"B Liang","year":"2016","unstructured":"Liang, B. et al. Mitochondria-targeted approach: remarkably enhanced cellular bioactivities of TPP2a as selective inhibitor and probe toward TrxR. ACS Chem. Biol. 11, 425\u2013434 (2016).","journal-title":"ACS Chem. Biol."},{"key":"7633_CR26","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ccell.2017.03.003","volume":"31","author":"L Leanza","year":"2017","unstructured":"Leanza, L. et al. Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo. Cancer Cell 31, 516\u2013531 (2017).","journal-title":"Cancer Cell"},{"key":"7633_CR27","doi-asserted-by":"publisher","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","volume":"117","author":"J Zielonka","year":"2017","unstructured":"Zielonka, J. et al. Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem. Rev. 117, 10043\u201310120 (2017).","journal-title":"Chem. Rev."},{"key":"7633_CR28","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1021\/acs.jmedchem.7b00679","volume":"60","author":"Y Ye","year":"2017","unstructured":"Ye, Y. et al. Mitochondria-targeted lupane triterpenoid derivatives and their selective apoptosis-inducing anticancer mechanisms. J. Med. Chem. 60, 6353\u20136363 (2017).","journal-title":"J. Med. Chem."},{"key":"7633_CR29","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nchembio.2007.5","volume":"3","author":"J Gershenzon","year":"2007","unstructured":"Gershenzon, J. & Dudareva, N. The function of terpene natural products in the natural world. Nat. Chem. Biol. 3, 408\u2013414 (2007).","journal-title":"Nat. Chem. Biol."},{"key":"7633_CR30","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1128\/EC.3.6.1639-1652.2004","volume":"3","author":"AT Coste","year":"2004","unstructured":"Coste, A. T., Karababa, M., Ischer, F., Bille, J. & Sanglard, D. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot. Cell 3, 1639\u20131652 (2004).","journal-title":"Eukaryot. Cell"},{"key":"7633_CR31","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1365-2958.2008.06309.x","volume":"69","author":"N Dunkel","year":"2008","unstructured":"Dunkel, N., Blass, J., Rogers, P. D. & Morschh\u00e4user, J. Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Mol. Microbiol. 69, 827\u2013840 (2008).","journal-title":"Mol. Microbiol."},{"key":"7633_CR32","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/EC.00215-12","volume":"11","author":"SA Flowers","year":"2012","unstructured":"Flowers, S. A. et al. Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans. Eukaryot. Cell 11, 1289\u20131299 (2012).","journal-title":"Eukaryot. Cell"},{"key":"7633_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1128\/EC.00245-13","volume":"13","author":"A Lohberger","year":"2014","unstructured":"Lohberger, A., Coste, A. T. & Sanglard, D. Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence. Eukaryot. Cell 13, 127\u2013142 (2014).","journal-title":"Eukaryot. Cell"},{"key":"7633_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.marenvres.2004.03.017","volume":"58","author":"T Luckenbach","year":"2004","unstructured":"Luckenbach, T., Corsi, I. & Epel, D. Fatal attraction: synthetic musk fragrances compromise multixenobiotic defense systems in mussels. Mar. Environ. Res. 58, 215\u2013219 (2004).","journal-title":"Mar. Environ. Res."},{"key":"7633_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1083\/jcb.147.5.959","volume":"147","author":"U Ahting","year":"1999","unstructured":"Ahting, U. et al. The Tom core complex the general protein import pore of the outer membrane of mitochondria. J. Cell. Biol. 147, 959\u2013968 (1999).","journal-title":"J. Cell. Biol."},{"key":"7633_CR36","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.bbamcr.2015.04.021","volume":"1853","author":"J Melin","year":"2015","unstructured":"Melin, J. et al. A presequence-binding groove in Tom70 supports import of Mdl1 into mitochondria. Biochim. Biophys. Acta 1853, 1850\u20131859 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"7633_CR37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrm2952","volume":"11","author":"SW Tait","year":"2010","unstructured":"Tait, S. W. & Green, D. R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11, 621\u2013632 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"7633_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.freeradbiomed.2009.05.004","volume":"47","author":"AJ Kowaltowski","year":"2009","unstructured":"Kowaltowski, A. J., de Souza-Pinto, N. C., Castilho, R. F. & Vercesi, A. E. Mitochondria and reactive oxygen species. Free Radic. Biol. Med. 47, 333\u2013343 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"7633_CR39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/pathogens4030457","volume":"4","author":"F Akbari","year":"2015","unstructured":"Akbari, F. & Kjellerup, B. V. Elimination of bloodstream infections associated with Candida albicans biofilm in intravascular catheters. Pathogens 4, 457\u2013469 (2015).","journal-title":"Pathogens"},{"key":"7633_CR40","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1128\/JCM.00131-07","volume":"45","author":"M Tumbarello","year":"2007","unstructured":"Tumbarello, M. et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J. Clin. Microbiol. 45, 1843\u20131850 (2007).","journal-title":"J. Clin. Microbiol."},{"key":"7633_CR41","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1128\/AAC.00684-06","volume":"50","author":"MD Lafleur","year":"2006","unstructured":"Lafleur, M. D., Kumamoto, C. A. & Lewis, K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 50, 3839\u20133846 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7633_CR42","unstructured":"World Health Organization. Antimicrobial Resistance: Global Report on Surveillance (WHO Press, Geneva, Switzerland, 2014)."},{"key":"7633_CR43","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.1176667","volume":"325","author":"MA Fischbach","year":"2009","unstructured":"Fischbach, M. A. & Walsh, C. T. Antibiotics for emerging pathogens. Science 325, 1089\u20131093 (2009).","journal-title":"Science"},{"key":"7633_CR44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1126\/science.1222236","volume":"336","author":"GD Brown","year":"2012","unstructured":"Brown, G. D., Denning, D. W. & Levitz, S. M. Tackling human fungal infections. Science 336, 647 (2012).","journal-title":"Science"},{"key":"7633_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-pharmtox-010611-134529","volume":"52","author":"MK Degorter","year":"2012","unstructured":"Degorter, M. K., Xia, C. Q., Yang, J. J. & Kim, R. B. Drug transporters in drug efficacy and toxicity. Annu. Rev. Pharmacol. Toxicol. 52, 249\u2013273 (2012).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"7633_CR46","first-page":"2014","volume":"1855-1869","author":"H Guedouari","year":"1842","unstructured":"Guedouari, H. et al. Changes in glutathione-dependent redox status and mitochondrial energetic strategies are part of the adaptive response during the filamentation process in Candida albicans. Biochim. Biophys. Acta 1855\u20131869, 2014 (1842).","journal-title":"Biochim. Biophys. Acta"},{"key":"7633_CR47","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/cmi.12438","volume":"17","author":"X She","year":"2015","unstructured":"She, X. et al. Fungal-specific subunits of the Candida albicans mitochondrial complex I drive diverse cell functions including cell wall synthesis. Cell Microbiol. 17, 1350\u20131364 (2015).","journal-title":"Cell Microbiol."},{"key":"7633_CR48","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.1128\/AAC.00889-13","volume":"57","author":"E Thomas","year":"2013","unstructured":"Thomas, E. et al. Mitochondria influence CDR1 efflux pump activity, Hog1-mediated oxidative stress pathway, iron homeostasis, and ergosterol levels in Candida albicans. Antimicrob. Agents Chemother. 57, 5580\u20135599 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7633_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nchembio.2534","volume":"14","author":"CA Mclellan","year":"2018","unstructured":"Mclellan, C. A. et al. Inhibiting mitochondrial phosphate transport as an unexploited antifungal strategy. Nat. Chem. Biol. 14, 135\u2013141 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"7633_CR50","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1021\/acs.jmedchem.5b00208","volume":"58","author":"Z Lin","year":"2015","unstructured":"Lin, Z. et al. ent-Kaurane diterpenoids from Chinese liverworts and their antitumor activities through michael addition as detected in situ by a fluorescence probe. J. Med. Chem. 58, 3944\u20133956 (2015).","journal-title":"J. Med. Chem."},{"key":"7633_CR51","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1021\/acs.jmedchem.6b00408","volume":"59","author":"S Xu","year":"2016","unstructured":"Xu, S. et al. Probing the anticancer action of oridonin with fluorescent analogues: visualizing subcellular localization to mitochondria. J. Med. Chem. 59, 5022\u20135034 (2016).","journal-title":"J. Med. Chem."},{"key":"7633_CR52","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1021\/acs.jmedchem.6b01652","volume":"60","author":"S Xu","year":"2017","unstructured":"Xu, S. et al. A novel potent anticancer compound optimized from a natural oridonin scaffold induces apoptosis and cell cycle arrest through the mitochondrial pathway. J. Med. Chem. 60, 1449\u20131468 (2017).","journal-title":"J. Med. Chem."},{"key":"7633_CR53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd3137","volume":"9","author":"S Fulda","year":"2010","unstructured":"Fulda, S., Galluzzi, L. & Kroemer, G. Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov. 9, 447\u2013464 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"7633_CR54","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1039\/b908260c","volume":"38","author":"S Noimark","year":"2009","unstructured":"Noimark, S., Dunnill, C. W., Wilson, M. & Parkin, I. P. The role of surfaces in catheter-associated infections. Chem. Soc. Rev. 38, 3435\u20133448 (2009).","journal-title":"Chem. Soc. Rev."},{"key":"7633_CR55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12281-014-0178-x","volume":"8","author":"SE Herwald","year":"2014","unstructured":"Herwald, S. E. & Kumamoto, C. A. Candida albicans niche specialization: features that distinguish biofilm cells from commensal cells. Curr. Fungal Infect. Rep. 8, 179\u2013184 (2014).","journal-title":"Curr. Fungal Infect. Rep."},{"key":"7633_CR56","first-page":"42","volume":"20","author":"G Ramage","year":"2001","unstructured":"Ramage, G., Wickes, B. L. & Lopez-Ribot, J. L. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am. Clin. Lab. 20, 42\u201344 (2001).","journal-title":"Am. Clin. Lab."},{"key":"7633_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrmicro2475","volume":"9","author":"JS Finkel","year":"2011","unstructured":"Finkel, J. S. & Mitchell, A. P. Genetic control of Candida albicans biofilm development. Nat. Rev. Microbiol. 9, 109\u2013118 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"7633_CR58","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3109\/10408410903241436","volume":"35","author":"G Ramage","year":"2009","unstructured":"Ramage, G., Mowat, E., Jones, B., Williams, C. & Lopezribot, J. Our current understanding of fungal biofilms. Crit. Rev. Microbiol. 35, 340\u2013355 (2009).","journal-title":"Crit. Rev. Microbiol."},{"key":"7633_CR59","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/CMR.00013-11","volume":"25","author":"BM Peters","year":"2012","unstructured":"Peters, B. M., Jabrarizk, M. A., O\u2019May, G. A., Costerton, J. W. & Shirtliff, M. E. Polymicrobial interactions: impact on pathogenesis and human disease. Clin. Microbiol. Rev. 25, 193\u2013213 (2012).","journal-title":"Clin. Microbiol. Rev."},{"key":"7633_CR60","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1128\/IAI.71.8.4333-4340.2003","volume":"71","author":"PK Mukherjee","year":"2003","unstructured":"Mukherjee, P. K., Chandra, J., Kuhn, D. M. & Ghannoum, M. A. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect. Immun. 71, 4333\u20134340 (2003).","journal-title":"Infect. Immun."},{"key":"7633_CR61","doi-asserted-by":"publisher","first-page":"14637","DOI":"10.1073\/pnas.141366998","volume":"98","author":"EJ Helmerhorst","year":"2001","unstructured":"Helmerhorst, E. J., Troxler, R. F. & Oppenheim, F. G. The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc. Natl. Acad. Sci. USA 98, 14637\u201314642 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7633_CR62","doi-asserted-by":"publisher","first-page":"10135","DOI":"10.1021\/acs.jmedchem.7b01348","volume":"60","author":"S Lin","year":"2017","unstructured":"Lin, S. et al. Semisynthesis and biological evaluation of xanthone amphiphilics as selective, highly potent antifungal agents to combat fungal resistance. J. Med. Chem. 60, 10135\u201310150 (2017).","journal-title":"J. Med. Chem."},{"key":"7633_CR63","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.bbamcr.2016.06.002","volume":"1863","author":"B Zhang","year":"2016","unstructured":"Zhang, B. et al. The Candida albicans fimbrin Sac6 regulates oxidative stress response (OSR) and morphogenesis at the transcriptional level. Biochim. Biophys. Acta 1863, 2255\u20132266 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"7633_CR64","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1128\/AAC.02040-12","volume":"57","author":"LV Silva","year":"2013","unstructured":"Silva, L. V. et al. Milbemycins: more than efflux inhibitors for fungal pathogens. Antimicrob. Agents Chemother. 57, 873\u2013886 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7633_CR65","doi-asserted-by":"publisher","first-page":"e0128693","DOI":"10.1371\/journal.pone.0128693","volume":"10","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. Diorcinol D exerts fungicidal action against Candida albicans through cytoplasm membrane destruction and ROS accumulation. PLoS ONE 10, e0128693 (2015).","journal-title":"PLoS One"},{"key":"7633_CR66","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bbagen.2010.01.001","volume":"1800","author":"XZ Wu","year":"2010","unstructured":"Wu, X. Z., Chang, W. Q., Cheng, A. X., Sun, L. M. & Lou, H. X. Plagiochin E, an antifungal active macrocyclic bis(bibenzyl), induced apoptosis in Candida albicans through a metacaspase-dependent apoptotic pathway. Biochim. Biophys. Acta 1800, 439\u2013447 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"7633_CR67","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.bbagen.2011.02.001","volume":"1810","author":"WQ Chang","year":"2011","unstructured":"Chang, W. Q. et al. Retigeric acid B exerts antifungal effect through enhanced reactive oxygen species and decreased cAMP. Biochim. Biophys. Acta 1810, 569\u2013576 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"7633_CR68","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/AAC.45.9.2475-2479.2001","volume":"45","author":"G Ramage","year":"2001","unstructured":"Ramage, G., Vande-Walle, K., Wickes, B. L. & Lopez-Ribot, J. L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45, 2475\u20132479 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7633_CR69","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1248\/bpb.b12-00511","volume":"35","author":"W Chang","year":"2012","unstructured":"Chang, W. et al. Retigeric acid B enhances the efficacy of azoles combating the virulence and biofilm formation of Candida albicans. Biol. Pharm. Bull. 35, 1794\u20131801 (2012).","journal-title":"Biol. Pharm. Bull."},{"key":"7633_CR70","doi-asserted-by":"publisher","first-page":"eaan4044","DOI":"10.1126\/scitranslmed.aan4044","volume":"10","author":"AB De","year":"2018","unstructured":"De, A. B. et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci. Transl. Med. 10, eaan4044 (2018).","journal-title":"Sci. Transl. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07633-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T16:04:01Z","timestamp":1671552241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07633-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["7633"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-07633-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734570201.793562265","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"30 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5102"}}